Search Results 1591-1600 of 24529 for Phase

  1. Use Of Tecovirimat (TPOXX®) For Treatment Of Human Orthopoxvirus Infections - Mayo Clinic

    Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study To Evaluate The Effects Of Two Doses Of MBX-8025 In Subjects With Primary Biliary Cirrhosis - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. A Study of Using Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant - Mayo Clinic

    This randomized phase III trial studies how well caspofungin acetate works compared to fluconazole or voriconazole in preventing fungal infections in patients ...

  4. SGI-110 in Patients with Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) - Mayo Clinic

    Phase 1-2 dose escalation randomized study in patients with intermediate or high risk myelodysplastic syndromes (MDS) or acute myelogenous leukemia (AML). The ...

  5. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  7. ARrest RESpiraTory Failure From PNEUMONIA - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  9. A Master Protocol To Evaluate The Long-Term Safety Of (LY3527727) Pirtobrutinib - Mayo Clinic

    Study phase. 4. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. A Study Comparing the Safety of Tofacitinib versus Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis - Mayo Clinic

    Study phase. 4. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...